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Summary
The main purpose of this study was to
investigate whether contrast enhanced
magnetic resonance angiography (ce-MRA)
can replace intra-arterial digital subtraction
angiography (i.a.DSA) in liver transplan-
tation candidates, patients after pancreas-
kidney transplantation and living renal
donors. For this purpose we used a trade-off
model consisting of diagnostic strength,
costs aspects and the patient's acceptance
of the new technique ce-MRA compared to
the older technique i.a.DSA to decide on
replacement of i.a.DSA or not.
Besides this multi-perspective approach an
attempt has been made to optimize the ce-
MRA scan protocol for optimal diagnostic
strength, efficiency and time saving pur-
poses.
Chapter 1 provides a general introduction
to the technique ce-MRA and i.a.DSA and
its advantages and disadvantages. General
remarks about transplantation, in particular
liver, kidney and pancreas transplantation,
and some remarks about the trade-off
character give the reader some background
information.
At the end of the introduction chapter the
following questions are presented:
l. Can ce-MRA-MRI in the orthotopic
liver transplantation candidate replace
i.a.DSA?
2. Can ce-MRA-MRI in the potential
living (un)related renal donor replace
i.a.DSA?
3. Can oe-MRA-MRI in the patient with
suspected vascular or non-understood
problems after pancreas and/or kidney
transplantation replace i.a.DSA?
4. What are the financial consequences of
replacement of i.a.DSA by ce-MRA-
Mzu?
5. What is the opinion of the patient about
the examinations ce-MRA-MRI and
i.a.DSA? Which procedure is preferred
by the patient?
6. Is the proposed ce-MRA scan timing
scheme suitable for an optimal signal
intensity in the arterial, portal venous
and systemic venous system in the
abdomen ? Does a difference exist
between patients with cirrhosis (liver
transplantation candidates) and healthy
individuals with respect to the point in
time when the maximum sisnal
intensity occurs?
In chapter 2 we studied the diagnostic
value of ce-MRA compared to i.a.DSA in
50 patients with chronic liver disease in the
work up for an orthotopic liver transplan-
tation. No significant differences were
found in the diagnostic value for that part of
the arterial system that is considered impor-
tant for the transplant surgeon. The small
vessel detail was less in ce-MRA, but this
was not considered a drawback in this
patient group. With respect to the portal
venous, the porto-systemic collaterals and
the systemic venous system ce-MRA was
superior to i.a.DSA. Although better than
i.a.DSA also ce-MRA-MRI showed disap-
pointing results in the detection of hepato-
cellular carcinoma. We concluded that ce-
MRA-MRI has a superior diagnostic
strength compared to i.a.DSA in the
radiological work-up for liver transplan-
tation. Therefore ce-MRA-MRI should re-
place i.a.DSA in these patients.
In chapter 3 we reported the results of ce-
MRA in 26 living (un)related living renal
donors. Ce-MRA showed good and com-
parable results to i.a.DSA in the detection
of supemumerary renal arteries.
Ce-MRA depicted the renal veins much
better. This may be an advantage if the
nephrectomy is performed by laparoscopy.
Ce-MRA gave better parenchymal detail.
However, the urinary collecting system was
better depicted on i.a.DSA. In this patient
group we considered the less spatial reso-
lution an insurmountable problem to accept
ce-MRA as a replacement for i.a.DSA
because ce-MRA was unable to detect
fi bromuscular dysplasia.
In chapter 4 we investigated the diagnostic
value of ce-MRA-MRI in 29 patients with
suspected vascular or non-understood
problems after pancreas and/or kidney
transplantation compared to i.a.DSA. The
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depiction of the venous drainage from the
grafts was much better on oe-MRA-MRI.
Ce-MRA-MRI and i.a.DSA were of equal
value in the assessment of the perfusion in
the renal grafts. In the pancreatic grafts,
however, the perfusion was more easily
seen on ce-MRA-MRI.
The three-dimensional character of ce-
MRA made the evaluation of tortuous graft
arteries possible from any desired angle.
This was an advantage over i.a.DSA.
Disadvantages were artifacts of vascular
clips that suggested stenoses in the graft
arteries. A careful evaluation of the source
images should alert the radiologist on the
occurrence of these artifacts. The urinary
collecting system was better depicted on ce-
MRA-MRI compared to i.a.DSA. Because
the gadolinium contrast agents as used in
ce-MRA-MRI have a much higher safety
profile compared to the iodine contrast
agents in i.a.DSA, ce-MRA-MRI is prefer-
red over i.a.DSA to evaluate the patients
with suspected vascular or non-understood
problems after pancreas and/or kidney
transplantation as the first screening moda-
lity.
In chapter 5 the radiological costs aspects
of ce-MRA and i.a.DSA in 102 individuals
(50 liver transplantation candidates, 26
potential renal donors and 26 patient after
pancreas and/or kidney transplantation)
were compared. All these individuals had
ce-MRA-MRI and i.a.DSA within a three
days interval. In allthree patient groups ce-
MRA was less expensive than i.a.DSA (up
to 20%). To achieve these relatively low
costs in ce-MRA it is necessary that tech-
nicians perform the ce-MRA without the
radiologist involved in the scan procedure
itself. Moreover. efficient use of the MR
equipment is a prerequisite for the lower
costs in ce-MRA. The conclusion was that
it is justified to replace i.a.DSA by ce-MRA
in order to cut the spendings in health care.
In chapter 6 the acceptance of ce-MRA by
104 patients was compared to the accep-
tance of i.a.DSA. The liver transplantation
candidate, the living renal donor and the
patient after pancreas and/or kidney trans-
plantation, they all preferred ce-MRA over
i.a.DSA. The main reason for this
preference was the non-invasive character
of ce-MRA. Therefore the patients experi-
enced less pain and did not have an
obligatory bedrest after the examination. In
contrast, after i.a.DSA patients had bedrest
during four hours for safety reasons after an
invasive procedure. The majority of the
patients considered the bedrest as a pretty
big nuisance.
In general the patients experienced less
mental and physical strain during ce-MRA.
Only a small group with definitely a
claustrophobic predisposition experienced
much fear and felt uncomfortable in the
tight MR scanner. This small group will
therefore refuse MR in the future.
It could be concluded that ce-MRA was
better accepted than i.a.DSA by most
patients. Therefore there are from the
patient's point of view good reasons to
replace i.a.DSA by ce-MRA.
In chapter 7 a scantiming scheme to depict
the abdominal arterial, portal and systemic
veins with the highest signal intensity is
proposed and evaluated.
The arteries showed the highest signal
intensity on the first scan, the portal vein
and the renal vein on the scan after 30
seconds. The scan that starts after 60
seconds is optimal for the depiction of the
supra-renal inferior vena cava, the 90
second scan is optimal for the infra-renal
inferior vena cava. No differences were
found between 40 patients with cinhosis
and 20 healthy subjects. Therefore this
scantiming scheme can be used in all
patients, irrespective of possible underlying
liver cirrhosis.
Chapter 8 discusses the results of the
previous chapters and summarizes the
different advantages and disadvantages of




The answers to the questions raised in the
introduction are as follows:
l. Ce-MRA-MRI in the orthotopic liver
transplantation candidate can replace
i.a.DSA because it has a superior diag-
nostic strength.
2. Ce-MRA-MRI in the potential living
(un)related renal donor cannot replace
i.a.DSA because the spatial resolution
is too low to detect fibromuscular dys-
plasia. However, if the nephrectomy is
performed with a laparascopic tech-
nique, ce-MRA gives additional infor-
mation about the venous system that is
necessary for a safe procedure. With
that respect ce-MRA and i.a.DSA are
complementary.
3. The diagnostic value of ce-MRA-MRI
in the patient after pancreas and/or
kidney transplantation is enough to
replace i.a.DSA as the primary diag-
nostic procedure to demonstrate or
exclude a vascular cause of the im-
paired function. However, one has to be
aware of artifacts (especially surgical
clip artifacts) that may simulate ste-
noses. If in doubt, additional i.a.DSA
should be performed.
The radiological part of the work-up in
liver transplantation candidates, renal
donors and patients after pancreas and
kidney transplantation costs significant-
ly less if ce-MRA-MRI is performed
instead of i.a.DSA. Besides the high
diagnostic value this is an argument to
replace i.a.DSA in the liver transplanta-
tion candidate and the patient after pan-
creas and kidney transplantation.
Liver transplantation candidates, renal
donors and patients after pancreas and
kidney transplantation, they all prefer
ce-MRA over i.a.DSA. This is another
argument to replace i.a.DSA in the liver
transplantation candidate and the pa-
tient after pancreas and kidney trans-
plantation. The only exception is the
patient with severe claustrophobia and
patients with contra-indications for MR
like some ferromagnetic devices, they
will continue to have i.a.DSA.
The proposed ce-MRA scan timing
scheme is suitable for the depiction of
the arterial, the portal and the systemic
venous system in the abdomen with a
maximum signal intensity. No differ-
ence exists between patients with cir-
rhosis and healthy individuals. There-
fore the proposed scan timing scheme is
suitable for subjects with and without
cirrhosis.
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